The 424B prospectus supplement
What is a 424B prospectus supplement?
A 424B prospectus supplement is the document filed with the SEC and distributed to investors when a public company actually issues securities—equity, debt, or other instruments—using an active shelf registration (S-3 or other form). The 424B describes the specific terms of the offering: how many shares or bonds, at what price, when the offering closes, what the proceeds will be used for, and which underwriters are managing the sale.
The name "424B" comes from the SEC form number. The "B" indicates it is a prospectus supplement filed under Rule 424(b) of the Securities Act of 1933. It supplements (and incorporates by reference) the base prospectus and the company's prior SEC filings (10-K, 10-Qs, 8-Ks).
A 424B is distinct from the underlying shelf registration because it contains the specific, binding terms of a particular offering. If you buy securities in an offering, the 424B is the legal document that governs what you are buying. It is typically 10–30 pages because it does not repeat information already in the base prospectus or recent SEC filings.
For investors, the 424B is the key document to read when a company announces a new offering. It is short, focused, and binding. Unlike press releases or earnings call transcripts, which can be spun or misrepresented, the 424B is a legal document subject to securities fraud liability if it contains material misstatements. This makes it one of the most reliable sources of information about an offering.
Quick definition
A 424B prospectus supplement is the SEC form filed when a public company issues securities from an active shelf registration, detailing the specific terms: security type, amount, price, use of proceeds, underwriters, risk factors specific to the offering, and pricing details. It supplements the base prospectus and incorporated SEC filings. A 424B is the binding offer document for investors in a secondary offering or debt issuance.
Key takeaways
- A 424B prospectus supplement is filed and becomes effective when a company actually issues securities, distinguishing it from a preliminary prospectus or base prospectus.
- The 424B contains the specific pricing, amount, and terms of the offering; any material risk factors unique to the offering; and the use of proceeds.
- A 424B incorporates the company's base prospectus and recent SEC filings by reference, so investors must review the full suite of documents to understand the complete picture.
- The underwriter(s) are named in the 424B, along with details of the underwriting arrangement (firm commitment, best efforts, agency, etc.).
- For equity offerings, the 424B includes the offering price per share, the number of shares, expected proceeds, underwriting discount, and any lockup agreements on insider selling.
- For debt offerings, the 424B includes the interest rate (coupon), maturity date, credit rating (if rated), and any covenants or special terms (callability, conversion rights, etc.).
- A 424B is a one-time document for a specific offering; if the company issues securities again, it files a new 424B for that offering.
Structure and key sections of a 424B
A 424B prospectus supplement typically includes the following sections:
Summary of offering. A one-page summary of the terms: security type, amount, price, proceeds, use of proceeds, and underwriters.
Risk factors. If there are material risks specific to this offering (e.g., interest rate risk for floating-rate debt, or conversion risk for convertible bonds), they are disclosed here. General business risks are incorporated from prior SEC filings.
Capitalization and dilution. For equity offerings, a table showing shares outstanding before the offering, shares being issued, and pro forma shares outstanding after issuance and any related effects (e.g., if proceeds are used to buy back shares).
Price to public and underwriting discount. The offering price per share or principal amount per bond, the underwriting discount (typically 2–3% for equity, 0.5–2% for debt), and the net proceeds after discount.
Use of proceeds. Specific allocation of proceeds: "60% to general corporate purposes, 40% to debt repayment" or similar. If proceeds are earmarked for an acquisition, the 424B will name the target and describe the transaction.
Underwriting arrangement and compensation. Names of the lead underwriters and syndicate; the type of agreement (firm commitment, best efforts, etc.); and compensation details (underwriting discount, selling concessions, reallowment).
Capitalization and dividend information. For equity offerings, details on dividend policy (if any), prior buyback history, and any restrictions on dividends.
Description of securities. If issuing a new class of security (e.g., convertible preferred stock), a detailed description of rights, preferences, privileges, and conversion or redemption terms.
Management discussion of financial condition and use of proceeds. A brief MD&A update addressing any material changes since the most recent 10-K or 10-Q, if this is a secondary equity offering.
Underwriter stabilization and market-making disclosure. A statement that underwriters may engage in stabilization activities to support the offering price, and a description of how such activities would be disclosed.
Incorporation by reference. A statement that the company's most recent 10-K, all subsequent 10-Qs and 8-Ks, and the base prospectus are incorporated by reference and form part of this prospectus supplement.
Pricing and terms in equity offerings
When a company issues equity through a secondary offering (using a 424B), the pricing is a critical variable for existing shareholders because it determines the degree of dilution.
IPO vs secondary pricing. In an IPO (S-1), the underwriters and company work backwards from the desired valuation per share to determine how many shares to offer. In a secondary offering using an S-3 shelf (424B), the company is already trading, so the offering price is typically set at a small discount to the current trading price, often 2–3%.
This discount compensates underwriters for their work and ensures demand, but it also gives existing shareholders visibility into the terms. If the stock trades at $100, and the company issues at $97, existing shareholders can immediately calculate dilution: if 500 million shares are outstanding and the company issues 50 million new shares at $97, total capitalization increases to $55 billion (roughly), and each existing shareholder's ownership fraction declines by 50/550 = 9.1%.
Bought deals vs agency offerings. In a bought deal, the underwriters purchase the entire offering from the company upfront, assuming the risk and reward. The company receives cash immediately; underwriters then resell to investors. A bought deal signals strong demand and moves quickly (often overnight).
In an agency offering (or best-efforts offering), underwriters act as agents and commit only to best efforts to sell. The company is paid only as shares are sold. Agency offerings are slower and carry more risk that the offering will not fully sell, but they also signal less certainty about demand.
A 424B will specify which arrangement applies. A bought deal is usually a positive signal (demand is strong); an agency offering is more neutral.
Lockup agreements and insider selling restrictions. Many secondary offerings include lockup agreements that restrict insiders from selling their shares for a period (typically 180 days) after the offering closes. This prevents an immediate wave of insider selling that would depress the stock.
A 424B will disclose any lockup terms. The presence of lockups on insiders is actually good for public investors, because it aligns insider interests with public shareholders over the medium term. The absence of lockups (insiders can sell immediately) can be a red flag.
Accretion to existing shareholders. Calculate whether the offering is accretive or dilutive to EPS. If a company with $1 billion in net income and 500 million shares (so $2 EPS) issues 50 million shares at $100, and uses proceeds to earn 3% (in Treasuries, say), the new earnings are $1 billion + (50 million times $100 times 3%) = $1 billion + $150 million = $1.15 billion. Total shares are now 550 million, so EPS is $1.15 billion / 550 million = $2.09. Even though shareholding was diluted, EPS increased because the company earned a return (albeit low) on the capital.
Pricing and terms in debt offerings
When a company issues bonds or other debt through a 424B, the terms are quite different from equity offerings.
Coupon rate and yield. The prospectus supplement specifies the coupon rate (interest rate) the company will pay on the debt. This rate is set based on credit market conditions and the company's credit rating. Investment-grade companies (rated BBB- or higher by S&P, for example) can borrow at lower rates; below-investment-grade companies pay higher rates.
The yield on the debt is the effective interest rate including any discount or premium to par value. If the company issues $1 billion in bonds at par (100% of principal) with a 5% coupon, and the bonds are priced at 101% (a $10 million premium), the effective yield is slightly below 5%.
Term to maturity. The prospectus supplement specifies when the debt will mature. Terms range from two years (short-term debt) to 30+ years (long-term bonds). Longer-dated debt typically carries a higher coupon to compensate investors for duration risk and reinvestment risk.
Credit rating. If the debt is rated by one or more credit rating agencies (S&P, Moody's, Fitch), the rating is disclosed in the prospectus supplement. A rating of BBB or higher (investment-grade) is less risky; BB or below (below-investment-grade, or "junk") is riskier. The rating affects both the coupon the company must pay and the investor base (some investors, like pension funds, can only buy investment-grade debt).
Covenants and restrictions. The prospectus supplement details any financial covenants the company must maintain (e.g., maintaining a minimum debt-to-EBITDA ratio or minimum interest coverage ratio). These restrictions limit the company's financial flexibility if the business deteriorates.
Call or conversion provisions. Some bonds are callable, meaning the company can redeem them before maturity at a predetermined price. Callable bonds give the company the option to refinance if rates decline; from the bondholder's perspective, callability limits upside if the bond is trading above par.
Convertible bonds can be converted by the bondholder into common stock at a predetermined conversion price. Convertible bonds typically carry lower coupons than straight bonds (because the conversion feature provides upside), making them attractive to investors who expect stock price appreciation.
Credit quality and spread. The prospectus supplement includes information about the company's credit metrics (debt levels, interest coverage, leverage ratios). Underwriters price the bond based on its credit quality relative to comparable issuers. A tighter spread (lower coupon relative to benchmark rates) indicates lower perceived default risk; a wider spread indicates higher risk.
Use of proceeds: reading between the lines
The use of proceeds section in a 424B prospectus supplement tells you what management intends to do with the capital. This is not optional; if management specifies a use of proceeds, there is a legal obligation to deploy the capital in that manner (with limited flexibility for "general corporate purposes").
General corporate purposes. If the prospectus says proceeds will be used for "general corporate purposes," this means management has not yet decided and will retain full flexibility in deployment. This is neither good nor bad, but it should trigger scrutiny on your part. Ask: Does the company have capital constraints that justify this offering? What are the likely uses given the company's growth stage and market position?
Specific acquisitions. If the prospectus specifies that proceeds will be used to acquire Company X, you can evaluate that acquisition separately. The 424B will disclose the target, the purchase price, and the expected strategic rationale. You can research the target and form a view on whether the acquisition is value-creating.
Debt repayment. If proceeds will be used to pay down debt, this is usually constructive, especially if the company is over-leveraged. Debt paydown improves financial flexibility and reduces financial risk. However, if the company is issuing equity at a low valuation to pay down debt, that can be shareholder-unfavorable (because equity is being issued when it is cheap, locking in losses relative to intrinsic value).
Share buybacks. Some companies issue debt and use proceeds to buy back shares. From an EPS perspective, this can be accretive (if the company is earning a return on assets higher than the cost of debt). However, if the company is buying back shares while also raising other capital, there may be questions about whether buybacks are an efficient use of cash (versus investing in the core business or paying down debt).
Capital expenditures and growth investments. If proceeds will fund factory expansion, product development, or geographic expansion, you can evaluate whether that investment is likely to earn a return above the company's cost of capital. Prospectuses often include vague language like "funding growth initiatives," which requires you to look at historical capital allocation and management's track record.
Working capital. Some offerings allocate proceeds to "working capital and general corporate purposes." Working capital includes cash, receivables, and inventory needed to operate the business. For companies in periods of rapid growth, working capital needs can be substantial, and this use of proceeds is often reasonable.
Red flags in a 424B prospectus supplement
Sudden shift in use of proceeds. If a company filed an S-3 shelf one year ago promising to use proceeds for debt paydown, and the 424B now says proceeds will be used for an acquisition not previously disclosed, this suggests the company's plans have changed materially. Read the most recent 10-K and 10-Q to understand what triggered the shift.
Underpricing relative to recent trading. If the company's stock has been trading at $100, and it is now issuing at $80, this is a 20% discount—far more than the typical 2–3%. Such steep discounts suggest either weak demand or distress on the company's part (e.g., urgent capital needs). Investigate why the discount is so large.
Large issuance relative to existing shares. If the company is issuing 30% of existing shares, the dilution is severe. Unless proceeds are funding a transformational acquisition or the business is in a growth crisis, this level of dilution is shareholder-unfavorable.
Offering expenses and discount. Add the underwriting discount and offering expenses (legal, accounting, printing, roadshow costs). These can total 3–5% of the offering size, a material drag on capital raised. If the company is raising capital at high cost relative to the size of the offering, the transaction may not be economical.
Insider lockup violations or exemptions. If insiders are exempt from lockup agreements and can sell immediately after the offering closes, this suggests potential insider selling pressure. Conversely, if insiders are locked up but management is issuing a large equity offering while insiders hold illiquid shares, this can create moral hazard (insiders want the stock to rise to make their locked-up shares more valuable, independent of business fundamentals).
Vague or speculative use of proceeds. If the prospectus says "proceeds will be used for opportunities identified in due course," this is essentially blank-check financing. The company is raising capital without having a specific plan for deployment. This should raise questions about capital allocation discipline.
Reading a 424B: practical example
Suppose Microsoft issues a 424B prospectus supplement announcing a $10 billion debt offering with the following terms:
- Amount: $10 billion principal
- Coupon: 4.5% (with three tranches: $3B due 2026 at 3%, $4B due 2036 at 4.5%, $3B due 2056 at 5%)
- Rating: AA (investment-grade, reflecting Microsoft's strong credit)
- Underwriters: Goldman Sachs, JPMorgan, Bank of America, and a syndicate
- Use of proceeds: debt refinancing and general corporate purposes
- Pricing: 100% of par (no discount or premium)
As an investor, you would note:
- The coupon reflects current market rates and Microsoft's strong credit (AA means very low default risk).
- The offering is large, but Microsoft's market cap is $3+ trillion, so this is only 0.3% of market value—immaterial dilution.
- The proceeds are going to debt refinancing, which is constructive (presumably replacing higher-cost debt or extending maturity profile).
- Microsoft's cash position is strong, so this offering is likely opportunistic (refinancing at favorable rates) rather than urgent.
- The use of proceeds is vague ("general corporate purposes"), but given Microsoft's track record of capital discipline, this is not concerning.
You would then read the base prospectus and Microsoft's most recent 10-K to understand the business, competitive position, and financial condition. If all is stable, this is a routine refinancing and unlikely to have a major impact on Microsoft's valuation.
By contrast, if a smaller, less-stable company issued a 424B with a 7.5% coupon (reflecting higher default risk) and proceeds going to "general purposes," you would dig deeper into why the company is raising capital and whether the costs are justified.
Common mistakes investors make with 424Bs
Not reading the prospectus supplement at all. Many investors rely on the press release summarizing an offering, which is often spun to be positive. The prospectus supplement is the actual legal document and is far more reliable.
Confusing the 424B with the base prospectus. A 424B incorporates the base prospectus by reference. To fully understand an offering, you need to read both the 424B supplement and the base prospectus (or S-3 shelf). The 424B alone may not contain full risk factors or business description.
Not calculating true dilution. Some investors look at the number of shares issued and compare to existing shares, but fail to account for the fact that proceeds are being deployed into assets that may or may not earn a return. True dilution depends on the expected return on capital employed.
Assuming underwriter involvement means due diligence. Underwriters have a reputational interest in not being associated with fraudulent offerings, but they are not auditors or guarantors of the company's business model. Read the prospectus independently.
Ignoring use of proceeds shifts. If a company's stated use of proceeds in an S-3 shelf differs materially from the actual use in a 424B, this is a red flag. It suggests either that the company's circumstances changed materially, or that management's stated plans in the S-3 were not binding.
Not checking the effective date. A 424B is effective only on the date the SEC declares it effective, which is typically stated on the cover page or in a footnote. If you are reading a 424B dated six months ago and the company has released new information since (e.g., a missed forecast, an acquisition), the prospectus may no longer be current.
FAQ
Q: Can I buy securities directly in a 424B offering?
A: If you are a retail investor, you cannot typically participate in a 424B offering directly. Institutional investors (mutual funds, hedge funds, pension funds) and high-net-worth individuals can buy in the offering through underwriters. Retail investors can buy the securities in the secondary market (on the stock exchange) after the offering closes.
Q: What is the difference between a 424B4 and a 424B5?
A: A 424B4 is a prospectus supplement for an offering to be sold on a delayed or continuous basis after the SEC declares the prospectus effective. A 424B5 is a prospectus supplement where the offering price, amount, or other terms are not yet determined and will be set in a subsequent "free writing prospectus" filed shortly before the offering closes. For practical purposes, both 424B4 and 424B5 are prospectus supplements that must be filed with the SEC.
Q: If the prospectus supplement has an error, can I sue?
A: If the 424B contains a material misstatement or omission, you may have a securities fraud claim under Section 12(b) of the Securities Act of 1933 if you purchased in the offering, or under Section 10(b) of the Securities Exchange Act of 1934 if you purchased in the secondary market. However, securities fraud claims are subject to high pleading standards and require proving scienter (knowledge of the falsehood or reckless disregard for the truth).
Q: Does the company have to comply with the stated use of proceeds?
A: Generally, yes. If the prospectus states proceeds will be used for a specific purpose, the company is legally bound to deploy them in that manner. However, the SEC generally permits some flexibility for "general corporate purposes" or if material circumstances change. If a company materially diverges from stated use of proceeds, it faces potential SEC enforcement action and securities fraud liability.
Q: Can the underwriters' compensation exceed the stated underwriting discount?
A: Underwriters earn the stated underwriting discount, plus potentially selling concessions and reallowment commissions. The 424B will detail all of these. Additionally, underwriters may earn fees for advisory services (e.g., advising on capital structure). All compensation should be disclosed in the prospectus supplement.
Q: What happens if the 424B offering is oversubscribed?
A: If demand exceeds the available shares or bonds, underwriters exercise their "green shoe" or "over-allotment option," which typically allows them to sell up to 15% more than the originally stated amount. The 424B discloses whether such an option exists. If oversubscribed and no green shoe exists, underwriters will allocate shares/bonds to investors on a pro-rata basis.
Q: Is a bought deal better than an agency offering?
A: A bought deal is generally better for the company (faster closing, certainty of proceeds) and signals strong investor demand. An agency offering is more conservative and shifts some risk to the company. From an investor's perspective, both are acceptable; the key is to focus on pricing and use of proceeds, not the underwriting arrangement.
Real-world examples
Apple's 2023 debt offering. Apple issued a $7 billion debt offering through a 424B, with four tranches ranging from one-year floating-rate notes to 30-year bonds. Apple's strong credit rating (AA or better) allowed it to issue at attractive rates well below Treasury yields. The prospectus stated proceeds would be used for debt repayment and general corporate purposes. Apple's offering was routine refinancing, signaling no distress and a focus on optimizing the debt maturity profile.
Tesla's 2021 equity offering (ATM program). Tesla implemented an "at-the-market" (ATM) equity offering program, filed through a 424B, allowing it to issue shares opportunistically as the stock price rose. Tesla issued billions in shares during 2021–2022, using proceeds for general corporate purposes and debt reduction. The ATM program allowed Tesla to raise capital without large discrete offerings, reducing market disruption. However, the continuous nature of Tesla's issuances over two years resulted in significant shareholder dilution.
GE's 2023 debt offerings. General Electric, emerging from a restructuring, issued multiple 424B debt offerings to refinance existing debt and fund operations. GE's credit rating was lower than Apple's (BBB or lower), so it paid higher coupons (5–6%+). The higher rates reflected market skepticism about GE's business model and financial stability. The offerings succeeded, but at a higher cost of capital than a company with stronger credit metrics would have paid.
Related concepts
- S-3 shelf registration: The base registration statement on which a 424B supplement is filed. The S-3 remains effective for three years; 424B supplements are filed for specific offerings within that period.
- Free writing prospectus (FWP): A document issued by the company or underwriters that supplements the prospectus but is not filed with the SEC (under certain conditions). An FWP can be used for roadshow presentations or marketing materials.
- Preliminary prospectus (red herring): A prospectus filed before the final terms are set. It includes "price to be determined" and red warning text. A final prospectus or 424B replaces it once terms are finalized.
- Base prospectus: The prospectus filed with the S-3 shelf registration, incorporating by reference prior SEC filings. A 424B supplement supplements the base prospectus.
- Green shoe (over-allotment option): An option allowing underwriters to sell up to 15% more shares than originally registered, if demand is strong. The green shoe stabilizes pricing and allows underwriters to profit from strong demand.
Summary
A 424B prospectus supplement is the binding legal document filed when a public company actually issues securities. It details the specific terms—amount, price, coupon rate, maturity, use of proceeds—and incorporates the company's recent SEC filings and the base prospectus by reference.
For investors, the 424B is one of the most reliable sources of information about an offering, because it is a legal document subject to securities fraud liability if it contains material misstatements. Reading the 424B carefully—understanding the pricing, dilution, use of proceeds, and any risks specific to the offering—is essential due diligence for assessing whether an offering is value-creating or value-destroying for existing shareholders.
The 424B is typically short and can be read in 15–30 minutes. Combined with the company's most recent 10-K or 10-Q (for context), it provides a complete picture of what the company is doing and why. Investors who read 424B supplements carefully when companies issue securities gain a significant informational advantage, because they can assess capital allocation discipline and expected returns before the broader market has fully priced the offering.